scPharmaceuticals Inc (SCPH)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John H. Tucker
Employees:
30
2400 DISTRICT AVENUE, SUITE 310, BURLINGTON, MA 01803
617-517-0730

scPharmaceuticals Inc. engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is. delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms.

Data derived from most recent annual or quarterly report
Market Cap 234.013 Million Shares Outstanding27.434 Million Avg 30-day Volume 386.152 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.37
Price to Revenue0.0 Debt to Equity0.2986 EBITDA-25.888 Million
Price to Book Value3.1476 Operating Margin0.0 Enterprise Value104.619 Million
Current Ratio4.813 EPS Growth0.148 Quick Ratio4.615
1 Yr BETA 0.8033 52-week High/Low 10.38 / 3.68 Profit Margin0.0
Operating Cash Flow Growth9.3121 Altman Z-Score0.4523 Free Cash Flow to Firm -18.426 Million
Earnings Report2023-05-15
View SEC Filings from SCPH instead.

View recent insider trading info

scPharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SCPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SCPH

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-23 by TUCKER JOHN H
  • 4: filed on 2023-01-23 by NOKES RACHAEL
  • 4: filed on 2022-12-19 by NOKES RACHAEL
  • 4: filed on 2022-11-29 by ORBIMED ADVISORS LLC
  • 4: filed on 2022-10-11 by ROCKLAGE SCOTT M
  • 4: filed on 2022-10-11 by TUCKER JOHN H
  • 4: filed on 2022-09-08 by ROCKLAGE SCOTT M
  • 4: filed on 2022-06-15 by BONSTEIN SARA
  • 4: filed on 2022-06-15 by HUDSON FREDERICK M.
  • 4: filed on 2022-06-15 by VEITINGER KLAUS R DR

    • Events (8k)

  • 8-K: filed on 2023-03-22:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 8.01: Other Events
  • 8-K: filed on 2022-12-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-23:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-16:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TUCKER JOHN H PRESIDENT AND CEO

    • Officer
    • Director
    		 245,589 2023-01-19 2

    NOKES RACHAEL SEE REMARKS

    • Officer
    		 85,750 2022-12-15 1

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    ORBIMED GENESIS GP LLC

    • 10% Owner
    		 5,559,528 2022-11-25 1

    5AM PARTNERS IV, LLC

    5AM CO-INVESTORS IV, L.P.

    5AM OPPORTUNITIES I (GP), LLC

    5AM OPPORTUNITIES I, L.P.

    5AM VENTURES IV, L.P.

    DIEKMAN JOHN D

    ROCKLAGE SCOTT M

    SCHWAB ANDREW J.

    • 10% Owner
    		 2,734,852 2022-10-06 3

    SCHAEFFER LEONARD D

    • Director
    		 16,300 2022-06-14 1

    VEITINGER KLAUS R DR

    • Director
    		 16,300 2022-06-14 1

    HUDSON FREDERICK M.

    • Director
    		 16,300 2022-06-14 1

    KHATTAR JACK A.

    • Director
    		 16,300 2022-06-14 1

    BONSTEIN SARA

    • Director
    		 16,300 2022-06-14 1

    BAYLOR-HENRY MINNIE

    • Director
    		 16,300 2022-06-14 1

    ABRAHAM WILLIAM TOBER

    • Director
    		 16,300 2022-06-14 1

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    		 No longer subject to file 2021-03-12 0

    COLEMAN DOROTHY

    • Director
    		 0 2020-06-09 0

    AGGER METTE KIRSTINE

    • Director
    		 0 2020-06-09 0

    FREEMAN MASON

    • Director
    		 0 2020-06-09 0

    SCHWAB ANDREW J.

    • 10% Owner
    		 3,831,474 2020-05-26 0

    5AM OPPORTUNITIES I (GP), LLC

    5AM OPPORTUNITIES I, L.P.

    • SEE REMARKSSEE REMARKS
    		 578,034 2020-05-26 0

    RA CAPITAL MANAGEMENT, LLC

    RA CAPITAL HEALTHCARE FUND LP

    • 10% Owner
    		 3,247,005 2019-04-11 0

    PARMAR KUSH

    • Director
    		 0 2018-06-19 0

    IGNELZI TROY A. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2018-01-17 0

    CEESAY ABRAHAM CHIEF OPERATING OFFICER

    • Officer
    		 0 2018-01-17 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    ISALY SAMUEL D

    • 10% Owner
    		 3,409,865 2017-11-21 0

    SILVERSTEIN JONATHAN

    • Director
    		 No longer subject to file 2017-11-21 0

    SUN PHARMACEUTICAL INDUSTRIES LTD

    SHANGHVI DILIP S

    SUN PHARMA (NETHERLANDS) B.V.

    SUN PHARMACEUTICAL INDUSTRIES, INC.

    • 10% Owner
    		 2,167,679 2017-11-21 0

    5AM PARTNERS IV, LLC

    5AM VENTURES IV, L.P.

    5AM CO-INVESTORS IV, L.P.

    SCHWAB ANDREW J.

    DIEKMAN JOHN D

    ROCKLAGE SCOTT M

    • 10% Owner
    		 3,357,382 2017-11-21 0

    LUNDBECKFOND INVEST A/S

    • 10% Owner
    		 3,183,986 2017-11-21 0

    RA CAPITAL MANAGEMENT, LLC

    KOLCHINSKY PETER

    • 10% Owner
    		 2,857,143 2017-11-17 0

    GANDHI ABHAY

    • Director
    		 0 2017-11-16 0

    SUN PHARMACEUTICAL INDUSTRIES, INC.

    • 10% Owner
    		 0 2017-11-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SCPHARMACEUTICALS INC SCPH 2023-03-24 22:15:03 UTC 1.8425 2.9775 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 21:45:03 UTC 1.8418 2.9782 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 21:15:03 UTC 1.8418 2.9782 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 20:45:03 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 20:15:04 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 19:45:03 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 19:15:04 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 18:45:04 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 18:15:03 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 17:45:03 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 17:15:03 UTC 1.824 2.996 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 16:45:03 UTC 1.8787 2.9413 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 16:15:03 UTC 1.8787 2.9413 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 15:45:03 UTC 1.8787 2.9413 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 15:15:03 UTC 1.8787 2.9413 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 14:45:03 UTC 1.8787 2.9413 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 14:15:03 UTC 1.8787 2.9413 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 13:45:03 UTC 2.4568 2.1132 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 13:15:04 UTC 2.4568 2.1132 300000
    SCPHARMACEUTICALS INC SCPH 2023-03-24 12:45:03 UTC 2.4568 2.1132 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments